Central segments liver resection for pediatric tumors

Aim. To analyze the short-term outcomes of сentral segments liver resection in children, according to the initial experience.

Мethods. The data of patients with different centrally located liver neoplasms were analyzed. This retrospective study included three patients with hepatoblastoma, one observation of mesenchymal hamartoma of the liver and one patient with hepatocellular carcinoma. Different types of central liver resections were carried out in these patients between March and October 2018. The technical aspects and the short-term results are described.

Results. Median age of patients was 78 months (9 months – 12 years). Patients underwent: segmentectomy 4b, bisegmentectomy 4b, 5, threesegmentectomy 4, 5, 6, mesohepatectomy (anatomical segmentectomy 4, 5, 8) with biliary reconstruction for posterior liver segments, mesohepatectomy with anatomical segmentectomy 6 and atypical S2, 3 resection. Dindo–Clavien grade IIIa postoperative complication developed in one patient. Vascular complications and posthepatectomy liver failure were absent. The hospital stay ranged between 9 to 14 days. The median follow-up period came to 8 months (7–14 months). The overall and event free survival at the time of writing is 100%.

Conclusion. Resections of central liver segments in children are feasible and should be carried out in experiences in liver surgery centers.

1. Chan J., Perini M., Fink M., Nikfarjam M. The outcomes of central hepatectomy versus extended hepatectomy: a systematic review and meta-analysis. HPB (Oxford). 2018; 20 (6): 487–496. https://doi.org/10.1016/j.hpb.2017.12.008.

2. La Quaglia M.P., Shorter N.A., Blumgart L.H. Central hepatic resection for pediatric tumors. J. Pediatr. Surg. 2002; 37 (7): 986–989.

3. Fischer L., Cardenas C., Thorn M., Benner A., Grenacher L., Vetter M., Lehnert T., Klar E., Meinzer H.P., Lamadé W. Limits of Couinaud’s liver segment classification: a quantitative computer-based three-dimensional analysis. J. Comput. Assist. Tomogr. 2002; 26 (6): 962–967.

4. Iwatsuki S., Starzl T.E. Personal experience with 411 hepatic resections. Ann. Surg. 1988; 208 (4): 421–434.

5. Fong Y., Fortner J., Sun R.L., Brennan M.F., Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 1999; 230 (3): 309–318.

6. Amesty M.V., Chocarro G., Vilanova Sánchez A., Nuñez Cerezo V., de la Torre C.A., Encinas J.L., Gamez Arance M., Hernández F., Lopez Santamaria M. Mesohepatectomy for centrally located tumors in children. Eur. J. Pediatr. Surg. 2016; 26 (1): 128–132. https://doi.org/10.1055/s-0035-1568995.

7. Wu C.C., Ho W.L., Chen J.T., Tang C.S., Yeh D.C., Liu T.J., Peng F.K. Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure. J. Am. Coll. Surg. 1999; 188 (5): 508–515.

8. Chen X.P., Qiu F.Z., Lau W.Y., Zhang B.X., Chen Y.F., Zhang W.G., He S.Q. Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients. Int. J. Colorectal. Dis. 2008; 23 (5): 543–546.

9. Cheng C.H., Yu M.C., Wu T.H., Lee C.F., Chan K.M., Chou H.S., Lee W.C. Surgical resection of centrally located large hepatocellular carcinoma. Chang Gung Med. J. 2012; 35 (2): 178–191.

10. Sotiropoulos G.C., Lang H., Molmenti E.P., Kaiser G.M., Paul A., Broelsch C.E. Partial or complete mesohepatectomy combined with resection of the hilar bifurcation in cases of Klatskin tumors: a reasonable strategy? Am. J. Surg. 2009; 198 (2): 297–298. https://doi.org/10.1016/j.amjsurg.2008.11.022.

11. Towbin A.J., Meyers R.L., Woodley H., Miyazaki O., Weldon C.B., Morland B., Hiyama E., Czauderna P., Roebuck D.J., Tiao G.M. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr. Radiol. 2018; 48 (4): 536–554. https://doi.org/10.1007/s00247-018-4078-z.

12. Aronson D.C., Czauderna P., Maibach R., Perilongo G., Morland B. The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials. J. Indian Assoc. Pediatr. Surg. 2014; 19 (4): 201–207. https://doi.org/10.4103/0971-9261.142001.

13. Zsiros J., Brugieres L., Brock P., Roebuck D., Maibach R., Zimmermann A., Childs M., Pariente D., Laithier V., Otte J.B., Branchereau S., Aronson D., Rangaswami A., Ronghe M., Casanova M., Sullivan M., Morland B., Czauderna P., Perilongo G. International Childhood Liver Tumours Strategy Group (SIOPEL). Dose-dense cisplatin-based chemotherapy and surgery for children with high risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 2013; 14 (9): 834–842. https://doi.org/10.1016/S1470-2045(13)70272-9.

14. Liu A.P.Y., Ip J.J.K., Leung A.W.K., Luk C.W., Li C.H., Ho K.K.H., Lo R., Chan E.K.W., Chan A.C.Y., Chung P.H.Y., Chiang A.K.S. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong. Pediatr. Blood Cancer. 2019; 66 (1): e27482. https://doi.org/10.1002/pbc.27482.

15. Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann. Surg. 2004; 240 (2): 205–213.

16. Clavien P.A., Barkun J., de Oliveira M.L., Vauthey J.N., Dindo D., Schulick R.D., de Santibanes E., Pekolj J., Slanka menac K., Bassi C., Graf R., Vonlanthen R., Padbury R., Cameron J.L., Makuuchi M. The Clavien–Dindo classification of surgical complications: five-year experience. Ann. Surg. 2009; 250 (2): 187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2.

17. Michels N.A. Observations on the blood supply of the liver and gallbladder (200 dissections). In: Blood supply and anatomy of the upper abdominal organs, with a descriptive atlas. Philadelphia, PA: Lippincott, Williams & Wilkins. 1955; 547, 39 p.

18. Michels N.A. Newer anatomy of the liver and variant blood supply and collateral circulation. Am. J. Surg. 1966; 112 (3): 337–347. https://doi.org/10.1016/0002-9610(66)90201-7.

19. Nakamura T., Tanaka K., Kiuchi T., Kasahara M., Oike F., Ueda M., Kaihara S., Egawa H., Ozden I., Kobayashi N., Uemoto S. Anatomical variations and surgical strategies in right lobe living donor liver transplantation: lessons from 120 cases. Transplantation. 2002; 73 (12): 1896–1903.

20. Orguc S., Tercan M., Bozoklar A., Akyildiz M., Gurgan U., Celebi A., Nart D., Karasu Z., Icoz G., Zeytunlu M., Yuzer Y., Tokat Y., Kilic M. Variations of hepatic veins: helical computerized tomography experience in 100 consecutive living liver donors with emphasis on right lobe. Transplant. Proc. 2004; 36 (9): 2727–2732. https://doi.org/10.1016/j.transproceed.2004.10.006.

21. Varotti G., Gondolesi G.E., Goldman J., Wayne M., Florman S.S., Schwartz M.E., Miller C.M., Sukru E. Anatomic variations in right liver living donors. J. Am. Coll. Surg. 2004; 198 (4): 577–582.

22. Ohno Y., Furui J., Kanematsu T. Is a modified central bisegmentectomy a volume-saving operation for pediatric hepatoblastoma? J. Pediatr. Surg. 2004; 39 (1): E13–16.

23. Lee S.Y. Central hepatectomy for centrally located malignant liver tumors: A systematic review. World J. Hepatol. 2014; 6 (5): 347–357. https://doi.org/10.4254/wjh.v6.i5.347.

24. Czauderna P., Otte J.B., Aronson D.C., Gauthier F., Mackinlay G., Roebuck D., Plaschkes J., Perilongo G. Guidelines for surgical treatment of hepatoblastoma in the modern era – recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Pediatric Oncology (SIOPEL). Eur. J. Cancer. 2005; 41 (7): 1031–1036. https://doi.org/10.1016/j.ejca.2005.02.004.

25. Le N., Rivard D.C., Rentea R.M., Manalang M., Andrews W., Kane B., Hendrickson R.J. Right trisegmentectomy after portal vein embolization in a high-risk toddler with hepatoblastoma. Pediatr. Surg. Int. 2018; 34 (5): 573–578. https://doi.org/10.1007/s00383-018-4250-4.

26. Guérin F., Gauthier F., Martelli H., Fabre M., Baujard C., Franchi S., Branchereau S. Outcome of central hepatectomy for hepatoblastomas. J. Pediatr. Surg. 2010; 45 (3): 555–563. https://doi.org/10.1016/j.jpedsurg.2009.09.025.

27. Li J., Wang C., Song J., Chen N., Jiang L., Yang J., Yan L. Mesohepatectomy versus extended hemihepatectomies for centrally located liver tumors: a meta-analysis. Sci. Rep. 2017; 7 (1): 9329. https://doi.org/10.1038/s41598-017-09535-0.

28. Chen X., Li B., He W., Wei Y.G., Du Z.G., Jiang L. Mesohepatectomy versus extended hemihepatectomy for centrally located hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 2014; 13 (3): 264–270. https://doi.org/10.1016/S1499-3872(14)60253-8.

29. Chowdappa R., Sagar R.C., Ramesh S., Appaji L., Maneya P., Mukundapai M. Central hepatectomy (mesohepatectomy) by Double Liver Hanging Maneuver (DLHM) in a child with hepatoblastoma. Indian J. Surg. Oncol. 2019; 10 (1): 46–49. https://doi.org/10.1007/s13193-018-0823-x.

30. Hu R.H., Lee P.H., Chang Y.C., Ho M.C., Yu S.C. Treatment of centrally located hepatocellular carcinoma with central hepatectomy. Surgery. 2003; 133 (3): 251–256.

31. Chouillard E., Cherqui D., Tayar C., Brunetti F., Fagniez P.L. Anatomical bi- and trisegmentectomies as alternatives to extensive liver resections. Ann. Surg. 2003; 238 (1): 29–34.